Healthcare Services

Vaccine Technologies Market Evolving Due to Increasing Infectious Disease Burden and Global Travel

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Vaccine Technologies Market Expected To Reach Based On Its 2026 Value?

The vaccine technologies market has seen substantial expansion in recent times. Its value is projected to rise from $61.38 billion in 2025 to $67.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.3%. The historical growth of this market can be linked to factors like the expansion of national immunization initiatives, increased public health funding, advancements in vaccine production technologies, growth in infectious disease surveillance, and the establishment of global vaccine supply chains.

The market for vaccine technologies is projected to experience robust expansion over the coming years. Its value is anticipated to reach $99.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This projected growth during the forecast period is primarily driven by heightened investments in advanced vaccine platforms, a surge in the need for pandemic readiness solutions, the broadening of adult immunization initiatives, an intensifying focus on vaccines for non-infectious diseases, and the wider implementation of digital systems for vaccine tracking. Key trends expected during this period encompass the accelerated development of mRNA and recombinant vaccines, an intensified emphasis on platforms for rapid vaccine production, the increasing integration of innovative delivery methods, the enlargement of worldwide immunization efforts, and a greater prioritization of cold chain optimization.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24735&type=smp

Which Major Drivers Are Influencing The Expansion Of The Vaccine Technologies Market?

The vaccine technologies market is projected to grow significantly due to the increasing incidence of infectious diseases. Infectious diseases are illnesses caused by detrimental microorganisms such as bacteria, viruses, fungi, or parasites, which can be transmitted directly or indirectly among people. The heightened occurrence of these diseases is linked to increased travel, facilitating the rapid cross-border spread of pathogens. Vaccine technologies play a crucial role in treating infectious diseases by stimulating targeted immune responses, thereby helping to prevent and control infections. They also support public health endeavors by reducing the spread and severity of illnesses, leading to improved overall healthcare outcomes. For example, in February 2024, the UK Health Security Agency, a government body based in the UK, indicated that tuberculosis (a contagious bacterial infection primarily affecting the lungs) cases in England increased to 4,850 in 2023, representing a 10.7% rise from 4,380 cases in 2022. Hence, the rising prevalence of infectious diseases is a key factor driving the expansion of the vaccine technologies market.

What Are The Key Segment Divisions In The Vaccine Technologies Market Segment Structure?

The vaccine technologies market covered in this report is segmented –

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

2) By Route Of Administration: Parenteral, Oral, Nasal

3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases

4) By Age Group: Pediatric, Adults

5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

Which Trends Are Shaping The Vaccine Technologies Market?

Major companies operating in the vaccine technologies market are concentrating on developing innovative solutions, such as quadrivalent influenza vaccines, to ensure broader immunization coverage and minimize the risk of strain mismatch. Quadrivalent influenza vaccines are designed to protect against four influenza virus strains, specifically two influenza A and two influenza B viruses, providing more extensive protection than trivalent vaccines. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, introduced VaxiFlu-4, a quadrivalent influenza vaccine. This vaccine offers seasonal protection against four influenza strains, including both influenza A and B types, is administered as a single-dose intramuscular injection, and is suitable for use in both adults and children. It helps mitigate the burden of seasonal influenza by offering wider strain coverage compared to traditional trivalent vaccines.

Which Organizations Are Engaged In The Vaccine Technologies Market?

Major companies operating in the vaccine technologies market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited

Get The Full Vaccine Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

Which Region Is The Top Contributor To The Vaccine Technologies Market By Share?

North America was the largest region in the vaccine technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Vaccine Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/vaccine-technologies-global-market-report

Browse Through More Reports Similar to the Global Vaccine Technologies Market 2026, By The Business Research Company

Swine Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Typhoid Vi Polysaccharide Vaccine Market Report

https://www.thebusinessresearchcompany.com/report/typhoid-vi-polysaccharide-vaccine-global-market-report

Dog Vaccines Market Report

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795